Keyphrases
Aberrations
100%
Brain Metastases
100%
Brain Radiotherapy
7%
Breast Cancer
7%
Cancer Hospital
7%
Chemotherapy
7%
Circulating Tumor DNA (ctDNA)
7%
Clinical Features
7%
Current Treatment
7%
DNA Testing
7%
Family Gene
7%
Fibroblast Growth Factor Receptor 1 (FGFR1)
100%
Flt-1
14%
Genetic Aberrations
21%
Genetic Events
7%
Genetic Testing
7%
HER2 Positivity
7%
HER2-positive
7%
Hunan
7%
Immunohistochemistry
7%
Ki-67
7%
Later-line
7%
Metastatic Brain Tumor
7%
Metastatic Breast Cancer
100%
Overall Survival
21%
Patients with Breast Cancer
7%
Poor Prognosis
100%
Predictive Factors
7%
Progression-free Survival
7%
Significant Risk Factors
14%
Survival Status
7%
Tumor Protein p53 (TP53)
14%
Medicine and Dentistry
Brain Metastasis
100%
Brain Radiation
9%
Breast Cancer
81%
Circulating Tumor DNA
9%
Clinical Feature
9%
Fibroblast Growth Factor Receptor
100%
Fibroblast Growth Factor Receptor 1
27%
Genetic Screening
9%
Immunohistochemistry
9%
Malignant Neoplasm
9%
Metastatic Breast Cancer
100%
Metastatic Carcinoma
72%
Overall Survival
27%
Predictive Factor
9%
Progression Free Survival
9%
Receptor Family
9%
Nursing and Health Professions
Area under the Curve
18%
Brain Metastasis
100%
Brain Radiation
9%
Breast Cancer
81%
Cancer Center
9%
Circulating Tumor DNA
9%
Clinical Feature
9%
Fibroblast Growth Factor Receptor
100%
Fibroblast Growth Factor Receptor 1
27%
Genetic Screening
9%
Immunohistochemistry
9%
Metastatic Breast Cancer
100%
Multigene Family
9%
Overall Survival
27%
Progression Free Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Metastasis
100%
Breast Cancer
81%
Chemotherapy
9%
Circulating Tumor DNA
9%
Clinical Feature
9%
Fibroblast Growth Factor Receptor
100%
Fibroblast Growth Factor Receptor 1
27%
Malignant Neoplasm
9%
Metastatic Breast Cancer
100%
Overall Survival
27%
Progression Free Survival
9%
Biochemistry, Genetics and Molecular Biology
Circulating Tumor DNA
14%
Fibroblast Growth Factor Receptor
100%
Fibroblast Growth Factor Receptor 1
42%
FLT1
28%
Genetic Screening
14%
Genetics
57%
Multigene Family
14%
Overall Survival
42%
Progression Free Survival
14%
Neuroscience
Circulating Tumor DNA
14%
Fibroblast Growth Factor Receptor
100%
Fibroblast Growth Factor Receptor 1
42%
Immunohistochemistry
14%
Intracranial Tumor
14%
Multigene Family
14%
Radiation Therapy
14%
Risk Factor
28%
TP53
28%